SIRPA and neoplasm: found that by binding signal regulatory protein α (SIRPα) to the surface of exosomes, which then interferes with the CD47-SIRPα interaction between cancer cells and bone marrow-derived macrophages, it can enhance tumor phagocytosis and significantly inhibit tumor growth.